- Home
- APLE vs HCM Comparison
APLE vs HCM Comparison
Compare APLE & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLE
- HCM
- Stock Information
- Founded
- APLE 2007
- HCM 2000
- Country
- APLE United States
- HCM Hong Kong
- Employees
- APLE N/A
- HCM N/A
- Industry
- APLE Real Estate Investment Trusts
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- APLE Real Estate
- HCM Health Care
- Exchange
- APLE Nasdaq
- HCM Nasdaq
- Market Cap
- APLE 2.8B
- HCM 2.5B
- IPO Year
- APLE 2015
- HCM N/A
- Fundamental
- Price
- APLE $12.12
- HCM $15.81
- Analyst Decision
- APLE Buy
- HCM Hold
- Analyst Count
- APLE 4
- HCM 1
- Target Price
- APLE $15.75
- HCM $19.00
- AVG Volume (30 Days)
- APLE 3.5M
- HCM 97.8K
- Earning Date
- APLE 08-06-2025
- HCM 08-07-2025
- Dividend Yield
- APLE 7.92%
- HCM N/A
- EPS Growth
- APLE N/A
- HCM N/A
- EPS
- APLE 0.79
- HCM 0.04
- Revenue
- APLE $1,429,658,000.00
- HCM $630,201,000.00
- Revenue This Year
- APLE $1.43
- HCM $14.86
- Revenue Next Year
- APLE $2.13
- HCM $19.54
- P/E Ratio
- APLE $15.25
- HCM $70.83
- Revenue Growth
- APLE 4.98
- HCM N/A
- 52 Week Low
- APLE $10.44
- HCM $11.51
- 52 Week High
- APLE $16.50
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- APLE 60.63
- HCM 55.21
- Support Level
- APLE $11.54
- HCM $14.86
- Resistance Level
- APLE $11.95
- HCM $16.00
- Average True Range (ATR)
- APLE 0.26
- HCM 0.33
- MACD
- APLE 0.07
- HCM -0.08
- Stochastic Oscillator
- APLE 95.78
- HCM 44.40
About APLE Apple Hospitality REIT Inc.
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.